Visualisation and subsets of the chemical universe database GDB-13 for virtual screening

被引:46
作者
Blum, Lorenz C. [1 ,2 ]
van Deursen, Ruud [1 ,2 ]
Reymond, Jean-Louis [1 ,2 ]
机构
[1] Univ Bern, Dept Chem & Biochem, CH-3012 Bern, Switzerland
[2] Univ Bern, Swiss Natl Ctr Competence Res, NCCR TransCure, CH-3012 Bern, Switzerland
基金
瑞士国家科学基金会;
关键词
Databases; Virtual screening; Chemical space; Enumeration; Fragments; MOLECULES; EXPLORATION; INHIBITORS; DISCOVERY; DESIGN;
D O I
10.1007/s10822-011-9436-y
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The chemical universe database GDB-13, which enumerates 977 million organic molecules up to 13 atoms of C, N, O, S and Cl following simple chemical stability and synthetic feasibility rules, represents a vast reservoir for new fragments. GDB-13 was classified using the MQN-system discussed in the preceding paper for the analysis of PubChem fragments. Two hundred and fifty-five subsets of GDB-13 were generated by the combinatorial use of eight restrictive criteria, including fragment-like ("rule of three") and scaffold-like (no acyclic carbon atoms) filters. Virtual screening for analogs of 15 commercial drugs of 13 non-hydrogen atoms or less shows that retrieving MQN-neighbors of a query molecule from GDB-13 or its subsets provides on average a 38-fold enrichment in structural analogs (Daylight-type substructure fingerprint Tanimoto T (SF) > 0.7), and a 75-fold enrichment in shape-similar analogs (ROCS TanimotoCombo score > 1.4). An MQN-searchable version of GDB-13 is provided at www.gdb.unibe.ch.
引用
收藏
页码:637 / 647
页数:11
相关论文
共 39 条
[1]   Cheminformatics approaches to analyze diversity in compound screening libraries [J].
Akella, Lakshmi B. ;
DeCaprio, David .
CURRENT OPINION IN CHEMICAL BIOLOGY, 2010, 14 (03) :325-330
[2]  
[Anonymous], 2010, Drug Discov Today Technol, V7, pe147, DOI 10.1016/j.ddtec.2010.11.010
[3]  
[Anonymous], 2002, Principal components analysis
[4]   970 Million Druglike Small Molecules for Virtual Screening in the Chemical Universe Database GDB-13 [J].
Blum, Lorenz C. ;
Reymond, Jean-Louis .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2009, 131 (25) :8732-+
[5]   Fragment-based lead discovery: leads by design [J].
Carr, RAE ;
Congreve, M ;
Murray, CW ;
Rees, DC .
DRUG DISCOVERY TODAY, 2005, 10 (14) :987-992
[6]   A rule of three for fragment-based lead discovery? [J].
Congreve, M ;
Carr, R ;
Murray, C ;
Jhoti, H .
DRUG DISCOVERY TODAY, 2003, 8 (19) :876-877
[7]   Drugging challenging targets using fragment-based approaches [J].
Coyne, Anthony G. ;
Scott, Duncan E. ;
Abell, Chris .
CURRENT OPINION IN CHEMICAL BIOLOGY, 2010, 14 (03) :299-307
[8]   Estimation of synthetic accessibility score of drug-like molecules based on molecular complexity and fragment contributions [J].
Ertl, Peter ;
Schuffenhauer, Ansgar .
JOURNAL OF CHEMINFORMATICS, 2009, 1
[9]   Virtual exploration of the small-molecule chemical universe below 160 daltons [J].
Fink, T ;
Bruggesser, H ;
Reymond, JL .
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2005, 44 (10) :1504-1508
[10]   Virtual exploration of the chemical universe up to 11 atoms of C, N, O, F: Assembly of 26.4 million structures (110.9 million stereoisomers) and analysis for new ring systems, stereochemistry, physicochemical properties, compound classes, and drug discovery [J].
Fink, Tobias ;
Reymond, Jean-Louis .
JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2007, 47 (02) :342-353